NL-OMON29626
Completed
Not Applicable
Generation of circulating tumor cell derived organoidsthrough enrichment by leukapheresis - A novel drug screening system in metastatic prostate cancer
Eramus Medical Center Rotterdam0 sites46 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Prostate cancerCRPCHSPCMetastatic prostate cancer
- Sponsor
- Eramus Medical Center Rotterdam
- Enrollment
- 46
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Investigators
Eligibility Criteria
Inclusion Criteria
- •Metastatic prostate cancer.
- •\- Intention to start (new) line of systemic treatment.
Exclusion Criteria
- •\- Low CTC count.
- •\- Patients with a known hypersensitivity to the used LA\-anticoagulant (ACD).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Generation of circulating tumor cell derived organoids through enrichment by leukapheresis - A novel drug screening system in metastatic prostate cancerNL-OMON46104Erasmus MC, Universitair Medisch Centrum Rotterdam79
Completed
Not Applicable
Characterization of Circulating Tumor Cells (CTC-s) in Patients With Locally Advanced or Metastatic Stage IV Breast CancerLocally Advanced Breast CancerMetastatic (Stage IV) Breast CancerStage III-IV Breast Cancer or InflammatoryNCT01048918City of Hope Medical Center280
Completed
Not Applicable
Circulating Tumor Cells in Solid TumorsSolid Tumor, AdultNCT03161821UNC Lineberger Comprehensive Cancer Center206
Unknown
Not Applicable
Cultured Circulating Tumor Cells in Prostate and Other CancersProstate CancerNCT02123862Oscar Goodman, Jr.220
Completed
Not Applicable
Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation TherapyCirculating Tumor CellsNCT02449837UNC Lineberger Comprehensive Cancer Center162